Target GLP-1R/GIPR/AmylinR therapy (Eccogene)

N/A

Report date: 2026/04/08 20:02:35
NME

Base Information

Drug NameTarget GLP-1R/GIPR/AmylinR therapy (Eccogene)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsGlucose-Dependent Insulinotropic Polypeptide Receptor agonistsAmylin receptor agonists
TargetsGlucagon-like peptide 1 receptorGlucose-Dependent Insulinotropic Polypeptide ReceptorAmylin Receptor
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEccogene (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEccogene (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A